Vikas Lifecare publishes Q3FY26 financial results in newspaper advertisement

1 min read     Updated on 25 Apr 2026, 01:43 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Vikas Lifecare Limited published newspaper advertisements of its Q3FY26 unaudited financial results in Financial Express and Jansatta newspapers on April 24-25, 2026, showing consolidated net loss of ₹2,927.64 lakhs and standalone net loss of ₹1,472.41 lakhs for the quarter ended December 31, 2025, following board approval and statutory auditor review.

powered bylight_fuzz_icon
38350212

*this image is generated using AI for illustrative purposes only.

Vikas Lifecare Limited published newspaper advertisements of its unaudited financial results for the quarter ended September 30, 2025, and quarter and nine months ended December 31, 2025, in compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Compliance

The company submitted copies of newspaper advertisements to both National Stock Exchange of India Limited and BSE Limited on April 25, 2026. The financial results were published in Financial Express (English Edition) and Jansatta (Hindi Edition) newspapers dated April 24 & 25, 2026.

Q3FY26 Financial Performance

The company's unaudited consolidated and standalone financial results show mixed performance across different quarters. The results were approved by the Board of Directors at their meeting held on April 21, 2026, following review by the Audit Committee.

Financial Metrics (₹ Lakhs): Q3FY26 Consolidated Q3FY26 Standalone Q2FY26 Consolidated
Total Income: 9,775.81 9,639.32 14,219.10
Total Expenses: 11,615.69 11,515.56 14,829.44
Profit/(Loss) Before Tax: (3,318.16) (1,876.24) (12,007.85)
Net Profit/(Loss): (2,927.64) (1,472.41) (11,896.04)
Basic/Diluted EPS: (0.04) (0.08) 0.03

Nine Months Performance

For the nine months ended December 31, 2025, the company reported total income of ₹46,560.00 lakhs on consolidated basis and ₹45,949.12 lakhs on standalone basis. The company maintained its paid-up equity share capital at ₹18,598.36 lakhs with face value of ₹1 each.

Board Approval and Documentation

The financial results received statutory auditor's limited review and were digitally signed by Managing Director Sundeep Kumar Dhawan (DIN: 09508137). The company's registered office is located at Vikas House, 3, Arihant Nagar, Punjabi Bagh West, New Delhi - 110026.

Manufacturing Facilities

Vikas Lifecare operates two manufacturing facilities - Factory I at G-83, Vigyan Nagar, RIICO Industrial Area, Shahjahanpur, Rajasthan, and Factory II at Plot No. 193, Baikampady, Mangaluru, Karnataka. The company maintains compliance with all regulatory requirements through proper documentation and timely submissions to stock exchanges.

Historical Stock Returns for Vikas Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
-2.45%-3.64%+30.33%-24.64%-40.00%-32.91%

What strategic measures is Vikas Lifecare planning to implement to reverse the consistent quarterly losses and return to profitability?

How might the company's declining financial performance impact its ability to secure funding for operations and expansion of its manufacturing facilities?

Will Vikas Lifecare consider restructuring its operations or divesting non-core assets to improve its financial position in upcoming quarters?

Vikas Lifecare Issues Postal Ballot Notice for Rs. 99 Cr Warrant Allotment Approval

2 min read     Updated on 15 Apr 2026, 08:17 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Vikas Lifecare Limited has issued a postal ballot notice seeking shareholder approval through remote e-voting for three key resolutions: issuance of 61,90,62,500 convertible warrants worth Rs. 99,05,00,000 to promoters and public investors, alteration of Articles of Association for future capital issuance, and increase in authorized share capital from Rs. 235 crores to Rs. 300 crores to accommodate growth requirements.

powered bylight_fuzz_icon
37237302

*this image is generated using AI for illustrative purposes only.

Vikas Lifecare Limited has issued a postal ballot notice seeking shareholder approval for its previously announced warrant allotment and related corporate actions. The company sent the notice to shareholders for remote e-voting on three key resolutions, including the issuance of 61,90,62,500 fully convertible warrants worth Rs. 99,05,00,000.

Postal Ballot Process Details

The company has engaged National Securities Depository Limited (NSDL) to facilitate the remote e-voting process. Shareholders holding shares as of the cut-off date of April 10, 2026, are eligible to participate in the voting process.

E-Voting Schedule: Timeline
Cut-off Date: April 10, 2026
Voting Commencement: April 16, 2026 (9:00 AM)
Voting Conclusion: May 15, 2026 (5:00 PM)
Notice Dispatch: April 15, 2026

Three Key Resolutions for Approval

The postal ballot notice covers three critical business items requiring shareholder consent. The first resolution seeks approval for alteration of Articles of Association to facilitate future capital issuance under Section 62 of the Companies Act, 2013.

Warrant Issuance Resolution

The second and most significant resolution pertains to the issuance of 61,90,62,500 fully convertible warrants on a preferential basis. These warrants, priced at Rs. 1.60 each, will be allocated to both promoter/promoter group entities and non-promoter public category investors.

Warrant Allocation: Details
Total Warrants: 61,90,62,500
Issue Price: Rs. 1.60 per warrant
Total Amount: Rs. 99,05,00,000
Promoter Allocation: 33,50,00,000 warrants
Public Allocation: 28,40,62,500 warrants

Major Allottee Distribution

Among promoter group entities, Just Right Life Limited will receive the largest allocation of 22,50,00,000 warrants, followed by Advikca Finvest Limited with 10,00,00,000 warrants. Individual promoter Vikas Garg is allocated 1,00,00,000 warrants.

In the non-promoter category, Sneha Garg leads with 9,37,50,000 warrants, while Integra Essentia Limited will receive 7,50,00,000 warrants. The allocation includes 25 different non-promoter entities and individuals.

Capital Structure Changes

The third resolution seeks approval for increasing the authorized share capital from Rs. 235,00,00,000 to Rs. 300,00,00,000, consisting of 300,00,00,000 equity shares of Re. 1 each. This increase will accommodate the proposed warrant conversion and future growth requirements.

Shareholding Impact: Pre-Issue Post-Conversion
Promoter Shares: 26,42,46,376 (14.22%) 59,92,46,376 (24.20%)
Public Shares: 1,59,34,22,184 (85.78%) 1,87,74,84,684 (75.80%)
Total Shares: 1,85,76,68,560 2,47,67,31,060

Regulatory Compliance Framework

The preferential issue will be conducted under Section 42 and Section 62(1)(c) of the Companies Act, 2013, and Chapter V of SEBI ICDR Regulations. The company has appointed Mr. Avinash Kumar of Avinash K & Co. as the scrutinizer for conducting the postal ballot process.

The warrants carry an 18-month conversion period from allotment date, with each warrant convertible into one fully paid-up equity share. The issue price of Rs. 1.60 per warrant is higher than the floor price determined under SEBI regulations, with the relevant date set as April 15, 2026.

Results of the postal ballot will be announced within two working days of the e-voting conclusion and communicated to stock exchanges where the company's shares are listed.

Source: Company/INE161L01027/171fd6a5-427f-4ad5-a0ac-234d989b12fd.pdf

Historical Stock Returns for Vikas Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
-2.45%-3.64%+30.33%-24.64%-40.00%-32.91%

How will the significant increase in promoter shareholding from 14.22% to 24.20% impact the company's governance structure and minority shareholder rights?

What strategic initiatives or expansion plans does Vikas Lifecare intend to fund with the Rs. 99.05 crore raised through this warrant issuance?

Given the 18-month conversion window, what factors might influence warrant holders' decisions to convert, and how could market conditions affect the conversion rate?

More News on Vikas Lifecare

1 Year Returns:-40.00%